# Notice of Intent to Sole Source: SnapGene Software Subscription Canonical: https://abierto.us/opportunities/75n91024noi6947509 - Solicitation number: 75N91024NOI6947509 - Notice type: Special notice - Status: Closed. Deadline was July 10, 2024 at 3:00 PM EDT - Department: Department of Health and Human Services - Agency: National Institutes of Health - Contracting office: NIH National Cancer Institute (75NC00) - NAICS: 513210 Software Publishers - Product or service code: 7A21 Business Application off-the-shelf software delivered by perpetual license, which also encompasses enterprise level software enabling mission capability and business operational support. - Place of performance: Bethesda, Maryland - County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031 - City: Bethesda. https://abierto.us/cities/bethesda-md-2407125 - First posted: July 3, 2024 - Last posted: July 3, 2024 - SAM.gov: https://sam.gov/workspace/contract/opp/676078dac7104eb59285bfcf5056b4c3/view ## Description The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR) plans to procure, on a sole source basis, SnapGene software licenses from: GSL Biotech, LLC., 225 FRANKLIN ST FL 26, BOSTON, MA, 02110 The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1 (b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 513210 and the business size standard is $47,000,000. The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR) has a robust molecular biology program. Researchers in this program require state-of-the-art, GLP-compliant software to design, visualize, and document commonly used molecular cloning techniques to conduct their research. The objective of this acquisition is to procure licenses to SnapGene software to aid CCR investigators in the design, visualization, and documentation of molecular biology experiments. SnapGene software is the only software on the market that can meet the Government’s requirements. SnapGene is a proprietary software of GSL Biotech, and there are no other re-sellers/providers of this software. Therefore, GSL Biotech is the only capable source for this acquisition. This notice is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the Government’s needs, it may submit a capability statement, proposal, or quote for the Government to consider. The response and any other information furnished must be in writing and must contain sufficient details to allow NCI to determine if the party can perform the requirement. Responses to this notice shall be submitted via email to Contracting Officer, Mark Brady, at mark.brady@nih.gov no later than 3:00 P.M. EST on Wednesday, July 10, 2024. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered for the purpose of determining whether to conduct a competitive procurement. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. To receive an award, Contractors must be registered and have valid certification through SAM.GOV. Please reference the notice number 75N91024NOI6947509 on all correspondence. ## Publications - July 3, 2024: Special notice, due July 10, 2024 at 3:00 PM EDT. Notice 676078dac7104eb59285bfcf5056b4c3. https://sam.gov/workspace/contract/opp/676078dac7104eb59285bfcf5056b4c3/view ## Points of contact - Mark Brady, mark.brady@nih.gov --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n91024noi6947509.